Chronic kidney disease (CKD) and hypertension exhibit a bidirectional relationship—declining renal function raises blood pressure, while persistent hypertension accelerates CKD progression, creating a harmful feedback loop documented in both experimental and clinical studies. The CRIC study revealed hypertension in 86% of adults with CKD, compared to 29% in the general population, with prevalence and treatment resistance increasing alongside CKD severity.1 According to the European Society of Hypertension (ESH) MASTERplan, effective hypertension management involves accurate BP measurement, patient assessment, therapy selection, and regular evaluation, with referrals for complex cases.2 Additionally, intensive blood pressure (BP) lowering reduces kidney failure risk by 17% and end-stage renal disease by 18%, particularly in proteinuric patients.3 ESH guidelines also advocate universal lifestyle modifications—healthy diet, regular exercise, weight control, reduced sodium, increased potassium, smoking cessation, stress management, and pollution avoidance—to delay disease progression.2